Related Experiment Videos
An attempt to demonstrate a Y-linked histocompatibility gene in the house mouse
Journal of the National Cancer Institute
|March 1, 1958
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Some new perspectives on transplantation immunity and tolerance.
Immunology today·2014
Learning a novel grapheme: effects of positional and phonemic context on children's spelling.
Journal of experimental child psychology·2001
The underwhite (uw) locus acts autonomously and reduces the production of melanin.
The Journal of investigative dermatology·2000
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.
Journal of the National Cancer Institute·2026
Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.
Journal of the National Cancer Institute·2026
Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.
Journal of the National Cancer Institute·2026
Redefining reach: inclusivity gaps in UK phase 3 head and neck trial protocols over the last decade.
Journal of the National Cancer Institute·2026
Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.
Journal of the National Cancer Institute·2026
Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.
Journal of the National Cancer Institute·2026
Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.
Transplantation proceedings·2026
Hypothermic Machine Perfusion Modifies the Impact of Cold Ischemia Time on Kidney Transplant Outcomes: A Single-Center Analysis.
Transplantation proceedings·2026
Feasibility of 8 Gy TBI-Busulfan-Fludarabine Conditioning with Post-Transplant Cyclophosphamide for Pediatric High-Risk or Relapsed Acute Lymphoblastic Leukemia.
Transplantation and cellular therapy·2026